arrow
G

Gil Awada

department of medical oncology
H指数:18
被引数:1,079

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy and safety of regorafenib in patients with advanced pretreated melanoma: results of the RegoMel phase II clinical trial

瑞戈非尼在经治晚期黑色素瘤患者中的疗效与安全性:RegoMel II期临床试验结果

2026-04-090
OAAI
Neoadjuvant nivolumab/relatlimab or nivolumab/ ipilimumab in triple negative breast cancer with high tumor-infiltrating lymphocytes (TILs)

新辅助尼沃鲁单抗/瑞拉利单抗或尼沃鲁单抗/伊匹木单抗在肿瘤浸润淋巴细胞(TILs)较高的三阴性乳腺癌中的应用

2024-09-010
PRE
Assessment of Retinal Pigment Epithelium Alterations and Chorioretinal Vascular Network Analyses in Patients under Treatment with BRAF/MEK Inhibitor for Different Malignancies: A Pilot Study

对接受BRAF/MEK抑制剂治疗的不同恶性肿瘤患者的视网膜色素上皮改变和脉络膜视网膜血管网络分析的评估: 一项初步研究

2023-02-031
OAAI
Intracerebral administration of CTLA-4 and PD-1 immune checkpoint blocking monoclonal antibodies in patients with recurrent glioblastoma: a phase I clinical trial
2021-06-2467
OAAI
Neurocognitive Function, Psychosocial Outcome, and Health-Related Quality of Life of the First-Generation Metastatic Melanoma Survivors Treated with Ipilimumab

Ipilimumab治疗的第一代转移性黑色素瘤幸存者的神经认知功能,社会心理结局和健康相关的生活质量

2020-07-2126
OAAI